Speciality · Hepatopancreatobiliary
Advanced surgical care for hepatopancreatobiliary malignancies — including complex pancreatic resections — backed by international training at Heidelberg University Hospital, one of Europe's leading pancreatic surgery centres.
Home / Specialities / HPB
Conditions treated
Including locally advanced disease — the focus of Dr. Akash's Visiting Fellowship at Heidelberg, Germany.
Highly prevalent in the Gangetic belt of North India; an area of Dr. Akash's published research.
Hepatocellular carcinoma and other primary liver tumours.
Cholangiocarcinoma of the intrahepatic and extrahepatic bile ducts.
Cancers arising near the ampulla of Vater, treated with pancreaticoduodenectomy.
Resectable secondary tumours, most commonly from colorectal cancer.
Warning signs
These symptoms do not always mean cancer — but they should never be ignored. Early evaluation makes treatment simpler and outcomes better.
The care pathway
Dr. Akash completed a Visiting Fellowship in advanced pancreatic surgery at Heidelberg University Hospital, Germany, under Prof. Christoph Michalski, and has published research on CEA & CA 19-9 as triage tools in gallbladder cancer in the Journal of Gastrointestinal Cancer.
Every case is planned through multidisciplinary discussion — so surgery, chemotherapy and radiation work together, in the right order, for the best outcome.
This page provides general educational information and is not a substitute for a medical consultation. Every cancer — and every patient — is different; please seek personalised advice.
Dr. Akash SrivastavaInternationally trained surgical oncologist — M.Ch. (Tata Memorial Hospital), Visiting Fellowship at Heidelberg University Hospital, Germany. UPMC Reg. No. 80409.